Revenue
No reported data
BIOVIE INC. (BIVI)
Price—Loading quote
Net income
2019
2020
2021
2022
2023
2024
2025
2026
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
2026
Financial statements
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research & development | $14.0M | $9.3M | $23.1M | $33.3M | $17.3M | $2.5M | $1.2M | $1.0M | $370,852 | $466,354 | $37,901 | $4,196 | $49,419 | — |
| Operating expenses | $22.7M | $18.1M | $32.2M | $45.1M | $27.3M | $138.1M | $2.7M | $2.5M | $2.4M | $1.6M | $432,028 | $233,377 | $322,385 | $17,515 |
| Operating income | −$22.7M | −$18.1M | −$32.2M | −$45.1M | −$27.3M | −$138.1M | −$2.7M | −$2.5M | −$2.4M | −$1.6M | −$432,028 | −$233,377 | — | — |
| Net income | −$22.1M | −$17.5M | −$32.1M | −$50.3M | −$26.1M | −$130.2M | −$16.7M | −$2.4M | −$2.4M | −$1.3M | −$431,923 | −$233,008 | −$321,896 | −$17,510 |
| Basic EPSper diluted share | -$3.05 | -$12.12 | -$73.05 | -$15.47 | -$1.06 | -$14.82 | -$6.85 | -$0.98 | -$0.03 | -$0.01 | $0.00 | $0.00 | $0.00 | $0.00 |
| Diluted EPSper diluted share | -$3.05 | -$12.12 | -$73.05 | -$15.47 | -$1.06 | -$14.82 | -$6.85 | -$0.98 | -$0.03 | -$0.01 | $0.00 | $0.00 | $0.00 | $0.00 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Aug 7, 2025Form 4 | DO CUONG VPresident & CEO | BuyCommon Stock · indirect | 5.0K | — | — | 10.0K |
| Aug 7, 2025Form 4 | DO CUONG VPresident & CEO | BuyWarrants (right to buy) · derivative · indirect | 5.0K | — | — | 5.0K |